Does DURVALUMAB Cause Hyperthyroidism? 125 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 125 reports of Hyperthyroidism have been filed in association with DURVALUMAB (IMFINZI). This represents 0.7% of all adverse event reports for DURVALUMAB.
125
Reports of Hyperthyroidism with DURVALUMAB
0.7%
of all DURVALUMAB reports
14
Deaths
32
Hospitalizations
How Dangerous Is Hyperthyroidism From DURVALUMAB?
Of the 125 reports, 14 (11.2%) resulted in death, 32 (25.6%) required hospitalization, and 11 (8.8%) were considered life-threatening.
Is Hyperthyroidism Listed in the Official Label?
Yes, Hyperthyroidism is listed as a known adverse reaction in the official FDA drug label for DURVALUMAB.
What Other Side Effects Does DURVALUMAB Cause?
Death (2,817)
Malignant neoplasm progression (1,330)
Pneumonitis (827)
Radiation pneumonitis (786)
Pyrexia (573)
Diarrhoea (530)
Pneumonia (453)
Dyspnoea (444)
Interstitial lung disease (430)
Off label use (395)
What Other Drugs Cause Hyperthyroidism?
LEVOTHYROXINE (1,681)
AMIODARONE (1,410)
NIVOLUMAB (934)
PEMBROLIZUMAB (780)
IPILIMUMAB (525)
CARBOPLATIN (432)
ATEZOLIZUMAB (416)
PACLITAXEL (261)
ALEMTUZUMAB (236)
LENVATINIB (231)
Which DURVALUMAB Alternatives Have Lower Hyperthyroidism Risk?
DURVALUMAB vs DUTASTERIDE
DURVALUMAB vs DUTASTERIDE\TAMSULOSIN
DURVALUMAB vs DUVELISIB
DURVALUMAB vs DYDROGESTERONE
DURVALUMAB vs EBASTINE